REQUEST A DEMO
Total
USD $0.00
Search more companies

Kolon Life Science Inc. (South Korea)

Main Activities: Other Chemical Product and Preparation Manufacturing | Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Full name: Kolon Life Science Inc. Profile Updated: December 01, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Kolon Life Science Inc. is engaged in manufacturing and distribution of biopharmaceutical products and eco-chemical businesses.The company develops allogeneic cell theraphy which is used for treatment of osteoarthritis; TissueGene-C (InvossaTM); Pain relief and vaccines for cancer patients. Kolon Life Science Inc. product porfolio includes Active Pharmaceutical Ingredients(API's), Antimicrobials and Water Solutions like KOLON BESFLOC Polymer which is used for chemical food, leather, pharmaceutical, fiber and dairy industry including waste and waste water treatment, plant settling pond, sludge thickener and float thickener. The company was established in 2000 and is based in Changwon,South Korea.

Headquarters
110, Magokdong 3-ro Gangseo-gu Seoul
Seoul; Seoul; Postal Code: 427709

Contact Details: Purchase the Kolon Life Science Inc. report to view the information.

Website: http://www.kolonls.co.kr/index.asp

Basic Information
Total Employees:
Purchase the Kolon Life Science Inc. report to view the information.
Outstanding Shares:
Purchase the Kolon Life Science Inc. report to view the information.
Registered Capital:
Purchase the Kolon Life Science Inc. report to view the information.
Financial Auditors:
Purchase the Kolon Life Science Inc. report to view the information.
Ratings:
Purchase the Kolon Life Science Inc. report to view the information.
Incorporation Date:
April 21, 2000
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
20.4%
Purchase this report to view the information.
14.4%
Purchase this report to view the information.
0.6%
Subsidiaries
Company Performance
Financial values in the chart are available after Kolon Life Science Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
7.17%
Total operating revenue
7.17%
Operating profit (EBIT)
N/A
EBITDA
336.85%
Net Profit (Loss) for the Period
N/A
Total assets
-15.79%
Total equity
-27.51%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
62.09%
Quick Ratio
-0.25%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?